TABLE 1

Patient Characteristics

Characteristic68Ga-PSMA-11 PET18F-PSMA-1007 PET
Patients (n)102102
Age at PET/CT (y)
 Median ± SD69 ± 770 ± 8
 Range50–8251–84
Initial Gleason score
 6–76363
 8–103939
Initial pathologic primary tumor stage
 ≤pT24646
 ≥pT35656
Initial pathologic regional LN stage
 pN07676
 pN12626
Additional ADT after RPE2424
PSA value before PET/CT (ng/mL)
 Median0.910.87
 Range0.18–30.000.20–13.59
 0.2–0.53535
 >0.5–1.02020
 >1.0–2.02121
 >2.02626
  • ADT = androgen deprivation therapy.